Oppenheimer Maintains Outperform on Xylem, Lowers Price Target to $158

Benzinga Newsdesk www.benzinga.com Negative 92.3%

Neg 92.3% Neu 0% Pos 0%

Oppenheimer analyst Bryan Blair maintains Xylem (NYSE:XYL) with a Outperform and lowers the price target from $160 to $158.